E-ISSN 2577-5669
 

Original Research 


Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions

Amjad H. Jawad*, Mufeed J. Ewadh, Rebee M. Hasani.

Abstract
A case-control study include 60 patients with beta-thalassemia major type with recurrent blood transfusion were visited
Babylon center of hereditary blood disorder in Babylon teaching hospital for maternity and children and 60 individuals
who seemed to be healthy. This study aimed to assess N-acetyl-beta-glucosaminidase and others renal function and
to look for renal complications in those patients if any. These patients and control groups divided into two subgroups
according to age, group I were less than 18 year and group II were equal or more than 18 years. The present study’s
findings showed that there was a significant difference in the levels of Albumin to creatinine ratio, Beta2-microglobulin,
N-Acetyl beta-D-glucosaminidase, serum creatinine level, and blood urea between patients group and its healthy group
(p < 0.05). In conclusion, beta-thalassemia major patients frequently have renal hemosiderosis and asymptomatic renal
impairment, which are not found in routine renal investigations, it needs regular checks for early detection of tubular
and glomerular failure

Key words: Beta 2 microglobulin ACR NAG,Renal hemosiderosis,Thalassemia major


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Amjad H. Jawad*
Articles by Mufeed J. Ewadh
Articles by Rebee M. Hasani
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

AHJ, Ewadh MJ, Hasani RM. Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. J Complement Med Res. 2022; 13(4): 73-76. doi:10.5455/jcmr.2022.13.04.15


Web Style

AHJ, Ewadh MJ, Hasani RM. Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. https://www.jocmr.com/?mno=117003 [Access: November 03, 2022]. doi:10.5455/jcmr.2022.13.04.15


AMA (American Medical Association) Style

AHJ, Ewadh MJ, Hasani RM. Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. J Complement Med Res. 2022; 13(4): 73-76. doi:10.5455/jcmr.2022.13.04.15



Vancouver/ICMJE Style

AHJ, Ewadh MJ, Hasani RM. Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. J Complement Med Res. (2022), [cited November 03, 2022]; 13(4): 73-76. doi:10.5455/jcmr.2022.13.04.15



Harvard Style

, A. H. J., Ewadh, . M. J. & Hasani, . R. M. (2022) Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. J Complement Med Res, 13 (4), 73-76. doi:10.5455/jcmr.2022.13.04.15



Turabian Style

, Amjad H. Jawad, Mufeed J. Ewadh, and Rebee M. Hasani. 2022. Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. Journal of Complementary Medicine Research, 13 (4), 73-76. doi:10.5455/jcmr.2022.13.04.15



Chicago Style

, Amjad H. Jawad, Mufeed J. Ewadh, and Rebee M. Hasani. "Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions." Journal of Complementary Medicine Research 13 (2022), 73-76. doi:10.5455/jcmr.2022.13.04.15



MLA (The Modern Language Association) Style

, Amjad H. Jawad, Mufeed J. Ewadh, and Rebee M. Hasani. "Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions." Journal of Complementary Medicine Research 13.4 (2022), 73-76. Print. doi:10.5455/jcmr.2022.13.04.15



APA (American Psychological Association) Style

, A. H. J., Ewadh, . M. J. & Hasani, . R. M. (2022) Assessment of Early marker of Renal Dysfunction in Patients with beta – Thalassemia Major with Repeated Blood Transfusions. Journal of Complementary Medicine Research, 13 (4), 73-76. doi:10.5455/jcmr.2022.13.04.15